Massachusetts Capital Resource Company, founded in 1977 and based in Boston, Massachusetts, serves as a private investment firm focused on addressing the funding gap for growing companies. The company provides risk capital in the form of mezzanine financing, long-term debt, and equity investments, specifically targeting emerging growth and middle-market firms. Its primary sectors of interest include manufacturing, distribution, service, and technology. By offering tailored investment solutions, Massachusetts Capital complements the financing available from senior lenders and equity investors, thereby supporting the growth and acquisition needs of companies operating in Massachusetts.

The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.

Enhanced Capital, established in 1999, is a New York-based investment firm managing over $400 million. It specializes in providing flexible equity and debt financing to small and mid-sized businesses, promoting their growth and expansion. The firm's investment approach is practical and tailored, aiming to maximize the growth potential of companies poised for rapid growth. Enhanced Capital also invests in renewable energy, historic real estate rehabilitation, and affordable housing projects, often leveraging federal and state incentive programs.

RA Capital Management is a Boston-based investment advisor founded in 2004, specializing in the life sciences and healthcare sectors. The firm focuses on early-stage companies developing innovative technologies, products, and services in drug development, medical devices, diagnostics, and research tools. With a team of professionals trained in biology, chemistry, and medicine, RA Capital Management leverages its extensive industry and business development experience to identify and invest in promising healthcare ventures. As a Registered Investment Adviser, the firm employs a strategic approach that includes both venture capital investments and a hedge fund strategy, targeting opportunities primarily in the United States and Europe.

MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, established in 2009. It supports early-stage entrepreneurs across various industries, including technology, healthcare, and social impact, by providing mentorship, resources, and networking opportunities. With locations in Israel, Mexico, Switzerland, Texas, and the UK, MassChallenge connects high-potential startups with industry experts and investors to foster innovation and facilitate growth. The accelerator operates on a non-equity model, allowing entrepreneurs to maintain full ownership of their companies while benefiting from strategic partnerships and tailored training programs. Through its diverse initiatives, such as targeted accelerator programs like MassChallenge HealthTech and FinTech, the organization aims to drive impactful change and enhance the global innovation ecosystem.

The U.S. Department of Energy is a government agency established in 1977, located in Washington, D.C. Its primary mission is to ensure the security and prosperity of the nation by tackling energy, environmental, and nuclear challenges. The Department focuses on promoting transformative scientific and technological solutions to address these issues, thereby supporting the country's energy needs and environmental sustainability.

MassVentures is a venture capital firm based in Waltham, Massachusetts, established in 1978 as a quasi-public corporation by the Massachusetts Legislature. The firm focuses on providing seed and early-stage funding to high-growth startups, facilitating their transition from concept to commercialization. MassVentures invests primarily in sectors such as information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics. With a governance structure that includes an independent Board of Directors and management by experienced venture capitalists, MassVentures leverages the state's entrepreneurial spirit and innovation centers to support the Massachusetts innovation economy. The firm also offers accelerator programs to further assist emerging companies in their growth journey.

General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.

Polaris Partners, established in 1996 and headquartered in Boston, Massachusetts, is a venture capital firm focusing on healthcare, life sciences, and biotechnology sectors. The firm invests across various stages, from early-stage companies to growth equity, partnering with repeat entrepreneurs and innovators. Polaris' healthcare portfolio spans digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics, while its life sciences and biotechnology investments center around molecules, platforms, therapeutics, and genomics. With offices in Boston and San Francisco, Polaris has a 20-year history of supporting companies that improve people's lives and work.

Atlas Venture, established in 1980, is a Cambridge, Massachusetts-based venture capital firm with a global presence. It manages over $2 billion in committed capital across multiple funds. The firm specializes in early-stage investing, focusing on life sciences and technology sectors. Atlas Venture creates and invests in biotech startups led by promising entrepreneurs, aiming to build scalable businesses and realize value. It typically invests $500,000 to $5 million in seed and early-stage rounds, with follow-on financing potentially reaching $10 to $20 million per company. Since 1995, Atlas Venture has been involved with over 350 companies, with 50 acquisitions and 40 IPOs.

Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.

Bain Capital, established in 1984, is a global multi-asset alternative investment firm with over $100 billion in assets under management. Headquartered in Boston, Massachusetts, the firm operates through several business units: Private Equity, Public Equity, Credit, and Venture Capital. Bain Capital Private Equity invests in various sectors, including consumer, healthcare, industrials, and technology, across North America, Europe, and Asia. Bain Capital Ventures, the venture capital arm, focuses on seed to growth-stage investments in enterprise software, infrastructure software, and industries being transformed by data. Bain Capital Life Sciences, a dedicated life sciences investment platform, invests in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics, and enabling life science technology companies globally. Bain Capital Double Impact, the firm's impact investing arm, builds great companies that deliver both competitive financial returns and meaningful, measurable social and environmental good.

Google.org is a philanthropic arm of Google, a multinational technology company. It funds and supports nonprofits globally, providing them with funding, tools, and volunteers. Google.org has committed approximately $100 million annually to these efforts, aiming to extend the reach of innovative nonprofits and create lasting global impact.

ARCH Venture Partners, established in 1986, is a U.S.-based venture capital firm with a global scope. It specializes in investing in technology companies, with a primary focus on life sciences. ARCH invests conservatively in seed rounds to mitigate risk, and then leads or co-leads subsequent financing rounds until liquidity. The firm is known for its success in commercializing technologies from academic research institutions and national laboratories, often investing in companies co-founded by scientists and entrepreneurs. ARCH has raised over $3 billion across ten funds and has invested in over 150 companies, typically committing between $50,000 and $150 million per company. It seeks a seat on the Board of Directors and maintains a presence in underserved geographic markets. ARCH's investors include corporations, pension funds, endowment funds, financial institutions, and private investors.

New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, headquartered in Menlo Park, California, with additional offices in the U.S., India, and China. NEA specializes in investing in technology and healthcare sectors, with a focus on enterprise, consumer, fintech, life sciences, and digital health companies. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. NEA invests globally, with a significant presence in Asia, including China and India, as well as the United States. The firm typically invests between $0.05 million and $20 million per deal.

Perceptive Advisors, established in 1999, is a New York-based investment management firm specializing in the life sciences sector. It invests in both private and public biotechnology, pharmaceutical, medical device, diagnostics, and health services companies across their lifecycle, from seed and early-stage ventures to public equities. The firm employs a long/short equity strategy and conducts in-house research to identify promising opportunities. Perceptive Advisors also offers customized debt financing solutions through its Perceptive Credit Opportunities Fund.

OrbiMed is a healthcare-focused investment firm based in New York City, established in 1989. The firm specializes in providing a range of financing solutions, including bridge loans, senior debt, and structured debt capital for both commercial-stage public and private healthcare companies. OrbiMed invests across various sectors within the healthcare industry, such as pharmaceuticals, life sciences, digital health, medical devices, biopharmaceuticals, diagnostics, healthcare technology, and biotechnology. With approximately $5 billion in assets under management, OrbiMed aims to support a spectrum of healthcare companies, from early-stage ventures to established multinational corporations.

Founder Collective, established in 2009 and headquartered in Cambridge, Massachusetts, with an additional office in New York, is a venture capital firm managed by entrepreneurs who have founded and sold technology companies. The firm focuses on seed-stage investments in technology-related companies across the United States, with a preference for the Boston and New York regions. Founder Collective aims to provide a user-friendly approach to venture capital, advising entrepreneurs to raise the least amount of money necessary to maintain control of their firms. The firm manages multiple funds, including Founder Collective I, II, III, and IV, investing between $0.2 to $2 million per round, primarily in the software and information technology sectors.

Insight Partners, established in 1995, is a global private equity and venture capital firm headquartered in New York City, with additional offices in London, Tel Aviv, and Palo Alto. The company specializes in investing in growth-stage technology and software companies, with a particular focus on sectors such as Fintech, Cybersecurity, AI/ML, DevOps, and Healthcare. As of December 31, 2022, Insight Partners has over $75 billion in regulatory assets under management. The firm has invested in more than 750 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Insight Partners' mission is to partner with visionary executives, providing practical, hands-on software expertise along their growth journey, from initial investment to IPO.

Founded in 1986, Morningside Group is a venture capital firm based in Newton, Massachusetts. The firm seeks to invest in companies operating in the technology, internet and biotechnology sectors.

The Massachusetts Clean Energy Center (MassCEC) is a state agency established to promote the growth of the clean energy sector in Massachusetts. Founded in 2009 under the Green Jobs Act, MassCEC focuses on accelerating job creation and economic development within the clean energy industry. The organization provides early-stage investments to startups, offers renewable energy rebates for residents and businesses, and supports workforce development initiatives to prepare individuals for careers in clean energy. By leveraging the state's unique assets, MassCEC aims to facilitate the development of renewable energy projects and establish Massachusetts as a leader in the national and global clean energy landscape.

Connecticut Innovations, founded in 1989 and based in New Haven, Connecticut, is a venture capital investment firm focused on high-tech industries, including energy, biotechnology, information technology, and photonics. The firm provides strategic capital and operational insight to companies at various stages of development, from seed to later stages. Its investment strategy encompasses a wide range of sectors, such as SaaS, manufacturing, life sciences, clean tech, oncology, cybersecurity, infrastructure, big data, e-commerce, and other technology-based fields. Connecticut Innovations aims to be the primary source of financing and support for innovative companies in Connecticut, offering flexible financing solutions, strategic guidance, and valuable connections to help businesses succeed and grow.

Accomplice is a Boston-based venture capital firm, with an additional office in San Francisco, specializing in seed and early-stage investments in technology startups. It primarily invests in companies focused on cybersecurity, eSports, data analytics, SMB class software, emerging hardware platforms, and marketplaces. Accomplice uniquely leverages community platforms like AngelList, Boston Syndicates, and Maiden Lane to empower and fund exceptional founders. With a majority of its investments in Boston and additional investments throughout the U.S., Canada, and the E.U., Accomplice is one of the most active early-stage firms in New England.

F-Prime Capital is a venture capital firm established in 1969 and headquartered in Cambridge, Massachusetts, with additional offices in San Francisco and London. It is part of the Fidelity Investments family, which has a long history of supporting entrepreneurs. F-Prime Capital focuses its investments on companies in North America and Europe, specializing in sectors such as healthcare, life sciences, therapeutics, fashion, medtech, health information technology and services, and technology. The firm emphasizes a hands-on approach, leveraging its deep industry expertise and extensive relationships to assist entrepreneurs in building significant companies. F-Prime Capital operates without the pressures of external fundraising, allowing it to concentrate on identifying and nurturing promising ventures.

Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and headquartered in Pasadena, California. It specializes in seed, early-stage, and growth capital investments primarily within the healthcare sector, with a particular emphasis on biopharma, diagnostics, life sciences, agrifood technology, and technology sectors. The firm is recognized for its strategic approach, providing long-term investment capital to innovative companies that are developing transformative technologies and therapies aimed at improving human health. As a subsidiary of Alexandria Real Estate Equities, Alexandria Venture Investments leverages its deep industry expertise, extensive relationships with investors, and a world-class scientific advisory network to support and fund promising startups and growth-oriented companies in disruptive life science and technology.

SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.

Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts, established in 2009. The firm specializes in investing in early-stage companies within the life sciences and biotechnology sectors. With a leadership team that has extensive experience in the industry, Mission BioCapital has a proven track record of launching and supporting numerous early-stage life science ventures. The firm operates in areas known for their significant research and development activities, which enhances its ability to identify promising investment opportunities. Portfolio company leaders recognize Mission BioCapital for its expertise and the substantial support it offers throughout the investment process.

SV Health Investors, established in 1993, is a prominent venture capital firm headquartered in Boston, Massachusetts. With over $2 billion in assets under management across seven private healthcare funds, the firm invests in innovative healthcare and life sciences companies across the United States and Europe. SV Health Investors focuses on supporting entrepreneurs developing breakthrough treatments and technologies, with a particular interest in therapeutics, biotechnology, healthcare services, and medical technology. The firm aims to transform healthcare through strategic investments, leveraging its 20-year track record and offices in Boston, San Francisco, and London.

Flagship Pioneering, established in 2000, is a Cambridge, Massachusetts-based company that conceives, develops, and grows innovative ventures in the realms of biology, medicine, and sustainability. It combines scientific expertise, entrepreneurial leadership, and strategic capital management to create first-in-category companies, aiming to transform human health and sustainability. The company's approach involves envisioning alternative futures and navigating transformational outcomes through an evolutionary methodology, starting with seemingly unreasonable propositions.

Casdin Capital is a New York-based investment firm established in 2012, specializing in fundamental research within the life sciences and healthcare sectors. The firm focuses on a range of investments, from early-stage to late-stage private opportunities, and is particularly interested in areas such as oncology, digital health, and agtech. As a Registered Investment Adviser, Casdin Capital employs a long-short equity strategy to manage its portfolio. Founded by Eli Casdin, the firm has built a reputation for its analytical approach to investing in innovative healthcare solutions, aiming to capitalize on advancements in the industry. As of October 2020, Casdin Capital managed approximately $2.2 billion in assets.

SoftBank Group is a multinational telecommunications and internet corporation based in Japan. It operates through four segments: mobile communications, Sprint, fixed-line telecommunications, and internet. The company provides a wide range of services, including mobile and fixed-line voice and data transmission services, broadband services, internet advertising, e-commerce, and digital television. SoftBank Group also invests in various technologies through its venture capital arms, such as SoftBank Investment Advisers and SoftBank Vision Fund, focusing on areas like artificial intelligence, robotics, and the Internet of Things. One of its notable subsidiaries, SoftBank Robotics, designs and manufactures humanoid robots for various applications, including education, healthcare, and business.

Accel, established in 1983, is a prominent venture capital firm headquartered in Palo Alto, California, with additional offices in San Francisco, London, and Bangalore. The firm specializes in investing in early and growth-stage technology startups, focusing on sectors such as software, cloud technologies, consumer services, enterprise, healthcare, fintech, and security. Accel's portfolio includes notable companies like Atlassian, Facebook, Slack, and Spotify, reflecting its ability to identify and support entrepreneurs building businesses that drive next-generation industries.

Battery Ventures, established in 1983 and headquartered in Boston, Massachusetts, is a technology-focused private equity and venture capital firm. It invests in early and growth-stage companies across various technology sectors, including application software, IT infrastructure, consumer internet, mobile services, and industrial technologies. The firm's investment strategy is global, targeting companies primarily in the United States, Europe, and Israel. Battery Ventures is registered as an Investment Adviser.

Deerfield Management, established in 1994 and headquartered in New York, is a healthcare-focused investment management firm. It provides long-term structured investments in both public and private healthcare companies, spanning life science, medical device, diagnostic, digital health, and health service industries. The firm also offers information and investment services to foster a healthcare ecosystem.

Matrix Partners, established in 1977, is a prominent venture capital firm headquartered in San Francisco, California. The firm focuses on early-stage and early-growth investments, partnering with entrepreneurs to build significant, industry-leading companies. With a global perspective and local expertise, Matrix combines the insights of former entrepreneurs and experienced investors to guide its portfolio companies. The firm has a proven track record, having invested in over 500 companies, with 50 going public and 75 achieving profitable M&A exits. Notable investments include Baidu, Apple, and Oculus. Matrix invests across various sectors, including applied AI, B2B SaaS, digital health, and sustainable-defined hardware.

The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.

Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.

Beacon Angels is a Boston-based angel group founded in 2006 that specializes in investing in early-stage and fast-growing companies in New England. The firm focuses on making investments ranging from $100,000 to $300,000, targeting businesses with high growth potential. Through its investment strategy, Beacon Angels aims to support and foster the development of small companies, contributing to the entrepreneurial landscape in the region.

MassMutual Ventures, established in 2014, is the venture capital arm of MassMutual Financial Group, a Fortune 500 insurance company founded in 1851. Based in Boston, Massachusetts, the firm invests in enterprise software-as-a-service, cybersecurity, health technology, financial technology, and climate technology sectors. MassMutual Ventures provides capital, connections, and advice to accelerate the growth of its portfolio companies, with a focus on enterprise software, cybersecurity, and fintech.

Samsara BioCapital LLC is a principal investment firm established in 2016 and located in Palo Alto, California. The company specializes in providing investment advisory services aimed at supporting biotechnology firms and entrepreneurs in transforming their ideas into successful ventures. It focuses on sectors such as healthcare, life sciences, oncology, and digital health, emphasizing innovation in the development of new therapies. Samsara BioCapital actively seeks to partner with ambitious and visionary companies, fostering collaboration to advance significant advancements in biotechnology.

The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency dedicated to fostering innovation within the life sciences sector in Massachusetts. Established under the Massachusetts Life Sciences Act, the Center's mission is to create jobs and enhance scientific research that benefits public health. It provides financial support to both public and private entities engaged in life sciences research, development, and commercialization, focusing on areas such as biopharma, medical devices, diagnostics, and digital health. The MLSC operates an Accelerator Loan Program aimed at offering working capital to early-stage life sciences companies with strong potential for growth and technology commercialization. Through these initiatives, the Center aims to strengthen the ties within the Massachusetts life sciences community and promote economic development driven by innovation.

Spark Capital, established in 2005, is a venture capital firm headquartered in Boston, Massachusetts, with additional offices in San Francisco and New York. The company invests across various stages and sectors, with a focus on internet, mobile, and technology-driven businesses. Notable investments include Twitter, Discord, and Oculus. Spark Capital typically invests between $0.5 million to $30 million, seeking board seats in its portfolio companies.

Invus Financial Advisors, LLC is an employee-owned investment firm based in New York, founded in 2006. The firm specializes in private equity investments and manages pooled investment vehicles, including hedge funds and funds of funds. Invus focuses on making direct and indirect investments in special situations, venture capital, and growth equity stages, with an emphasis on smaller companies and opportunistic co-investments. The firm adopts a flexible approach, recognizing the uniqueness of each company and the complexities of business transformation. Invus maintains a long-term commitment to its investments, aligning its incentives with those of its partners. With a history of empowering owner-managers since 1985 and a strong backing from a group of European families, Invus Financial Advisors manages over $4 billion in an evergreen fund and operates additional offices in London, Paris, and Hong Kong.

.406 Ventures, established in 2005 and headquartered in Boston, is a venture capital firm focusing on early-stage investments in the Northeast United States. The company specializes in enterprise IT sectors, with a particular interest in information technology security and infrastructure, cybersecurity, digital health, and next-generation software. They typically invest between $2 million to $5 million initially, with a total commitment of up to $10 million per company, often taking a minority or control stake and seeking board representation. As lead, first institutional investors, they aim to support market-changing companies and apply their industry expertise and networks to create value for entrepreneurs and partners.

LaunchCapital, established in 2008, is a venture capital firm headquartered in New Haven, Connecticut, with additional offices in Boston, New York, and San Francisco. The company invests in early-stage startups, focusing on seed rounds with investments typically ranging from $50,000 to $150,000. LaunchCapital supports entrepreneurs across various sectors, including commerce, marketplace, consumer, media, entertainment, enterprise software, emerging tech, data, finance, healthcare, and medical technology. The firm employs two distinct investment strategies: LaunchCapital Ventures, which follows a traditional equity model for high-growth opportunities, and LaunchCapital Small Business, which offers a blend of equity and debt financing for businesses with linear growth expectations and local or regional reach.

The Engine, established by the Massachusetts Institute of Technology (MIT) in 2016, is a venture firm focused on supporting early-stage companies that tackle significant global challenges through innovative science and engineering. The Engine prioritizes transformative ideas over immediate profitability, offering a streamlined system that accelerates the progression from concept to market. It provides a physical workspace for startups, along with essential resources such as business planning, legal assistance, and administrative support. The Engine also connects entrepreneurs with "patient capital" from like-minded investors, allowing startups to maintain greater control over their ventures. With plans to support up to 60 startups simultaneously over a 12-month period, The Engine aims to facilitate rapid development and validation of groundbreaking concepts. Additionally, it offers access to specialized equipment and lab space through the Engine Room, fostering a collaborative environment that nurtures innovation within the MIT community and beyond.

Foresite Capital, established in 2011, is a San Francisco-based healthcare and life sciences investment firm with approximately $2 billion under management. It takes a data-driven, collaborative approach to investing, providing not just capital but also a multidisciplinary team of experts to support its portfolio companies. Foresite focuses on growth equity investments across the U.S. healthcare sector, with a particular interest in startups that leverage biology, big data, and technology to improve healthcare outcomes. Its portfolio includes companies like 10x Genomics, Relay Therapeutics, and Element Biosciences. The firm aims to address areas of great unmet clinical need and supports promising healthcare and life sciences businesses at all stages of their development.

Northpond Ventures is a venture capital firm based in Bethesda, Maryland, with additional offices in San Francisco and Cambridge. Founded in 2018, the firm specializes in growth capital investments across various sectors, including life sciences, biotechnology, diagnostics, digital health, and emerging technologies. Northpond Ventures aims to support innovative companies that are poised to make significant advancements in healthcare and technology, with a focus on building a better future through its strategic investments. As a Registered Investment Adviser, the firm is committed to fostering developments in therapeutics, artificial intelligence, machine learning, and medical technology.

Advantage Capital, established in 1992, is a venture capital firm specializing in growth equity, lending, and mezzanine debt capital investments. It focuses on small businesses, particularly those in low-income communities and underserved areas, supporting state and local economic development efforts. The firm invests across various industries, including manufacturing, technology, business services, and renewable energy, with a typical initial investment range of $0.5 million to $10 million. Advantage Capital provides debt capital in forms such as senior debt, subordinated loans, and government-guaranteed lending, as well as equity capital to real estate development firms. It operates from multiple offices across the United States, with a headquarters in New Orleans, Louisiana.

T. Rowe Price Group, Inc., established in 1937 and headquartered in Baltimore, Maryland, is a global investment management firm. It serves a diverse range of clients, including individuals, institutional investors, retirement plans, and financial intermediaries. The company offers a broad spectrum of investment strategies, focusing on equity and fixed income markets worldwide. T. Rowe Price employs a fundamental, bottom-up approach, combining in-house and external research, and considers environmental, social, and governance factors in its investment decisions. With offices across North America, Europe, Asia, and Australia, the firm is committed to delivering long-term investment excellence.